Stay updated on Pembrolizumab in Thymic Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Thymic Tumors Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. A funding-status notice and the previous v3.4.1 revision were removed; these are administrative updates that do not affect study data or how to use the page.
    Difference
    0.5%
    Check dated 2026-02-11T02:37:13.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2026-02-03T23:47:38.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page now shows a glossary and the metadata revision is updated to v3.4.0, with minor capitalization changes in labels such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-27T23:48:00.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4; no content or functionality was changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:17:21.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Site maintenance notes show Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure (previous Revision: v3.3.2); no study details or data are affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T12:32:39.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Publications section now notes that entries are automatically filled from PubMed and displays Revision: v3.3.2. The previous wording about PubMed-derived publications has been replaced with updated phrasing.
    Difference
    0.1%
    Check dated 2025-11-24T20:51:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Thymic Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.